Transthyretin Amyloid Cardiomyopathy Enters Precision Era with Targeted Silencing and Stabilization
A comprehensive clinical review details how molecular diagnostics, artificial intelligence, and targeted therapies are reshaping the management of transthyretin amyloid ...











